Matthew Reynolds to Hospitalization
This is a "connection" page, showing publications Matthew Reynolds has written about Hospitalization.
Connection Strength
1.517
-
Ladapo JA, Turakhia MP, Ryan MP, Mollenkopf SA, Reynolds MR. Health Care Utilization and Expenditures Associated With Remote Monitoring in Patients With Implantable Cardiac Devices. Am J Cardiol. 2016 May 01; 117(9):1455-62.
Score: 0.293
-
Martin-Doyle W, Essebag V, Zimetbaum P, Reynolds MR. Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials. J Cardiovasc Electrophysiol. 2011 May; 22(5):548-53.
Score: 0.204
-
Reynolds MR, Morais E, Zimetbaum P. Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: results from an observational registry. Am Heart J. 2010 Oct; 160(4):752-8.
Score: 0.202
-
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.
Score: 0.125
-
Cannon CP, Khan I, Klimchak AC, Sanchez RJ, Sasiela WJ, Massaro JM, D'Agostino RB, Reynolds MR. Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease. Am Heart J. 2019 10; 216:30-41.
Score: 0.092
-
Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018 03; 15(3):355-362.
Score: 0.082
-
Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Am J Ther. 2014 Nov-Dec; 21(6):500-8.
Score: 0.067
-
Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL, Douglas PS, Svensson LG, Gada H, Thourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv. 2014 Dec; 7(6):829-36.
Score: 0.067
-
Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Mar 04; 63(8):788-96.
Score: 0.063
-
Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012 Mar 06; 125(9):1102-9.
Score: 0.055
-
Ladapo JA, David G, Gunnarsson CL, Hao SC, White SA, March JL, Reynolds MR. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol. 2012 Jan; 23(1):1-8.
Score: 0.053
-
Kotowycz MA, Filion KB, Joza J, Dube D, Reynolds MR, Pilote L, Eisenberg MJ, Essebag V. In-hospital management of atrial fibrillation: the CHADS2 score predicts increased cost. Can J Cardiol. 2011 Jul-Aug; 27(4):506-13.
Score: 0.053
-
Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun; 18(6):628-33.
Score: 0.040
-
Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d'Avila A, Zimetbaum PJ, Yeh RW, Kramer DB. Outcomes of Atrial Fibrillation Ablation Among Older Adults in the United States: A Nationwide Study. JACC Clin Electrophysiol. 2024 Jul; 10(7 Pt 1):1341-1350.
Score: 0.032
-
Culler SD, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Brown PP, Schlosser ML, Simon AW. Understanding Readmissions in Medicare Beneficiaries During the 90-Day Follow-Up Period of an Acute Myocardial Infarction Admission. J Am Heart Assoc. 2019 11 05; 8(21):e013513.
Score: 0.024
-
Culler SD, Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Schlosser ML, Simon AW. Impact of Complications on Resource Utilization During 90-Day Coronary Artery Bypass Graft Bundle for Medicare Beneficiaries. Ann Thorac Surg. 2019 May; 107(5):1364-1371.
Score: 0.022
-
Culler SD, Cohen DJ, Brown PP, Kugelmass AD, Reynolds MR, Ambrose K, Schlosser ML, Simon AW, Katz MR. Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has?Transcatheter Aortic Valve Replacement?Made a Difference? Ann Thorac Surg. 2018 04; 105(4):1137-1143.
Score: 0.021
-
Amin AP, Reynolds MR, Lei Y, Magnuson EA, Vilain K, Durtschi AJ, Simonton CA, Stone GW, Cohen DJ. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial). Am J Cardiol. 2012 Sep 15; 110(6):765-70.
Score: 0.014
-
Zimetbaum P, Reynolds MR, Ho KK, Gaziano T, McDonald MJ, McClennen S, Berezin R, Josephson ME, Cohen DJ. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003 Sep 15; 92(6):677-81.
Score: 0.008